Price T Rowe Associates Inc Protara Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$8.68 - $16.99 $2.77 Million - $5.43 Million	-319,326 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$13.75 - $23.86 $1.57 Million - $2.73 Million	-114,272 Reduced 26.35%	319,326 $5.03 Million
Q4 2020 Feb 16, 2021	BUY	$16.97 - $25.34 $7.36 Million - $11 Million	433,598 New	433,598 $10.5 Million

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $25.8M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.